Catalent, Inc.
NYSE:CTLT
59.41 (USD) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Catalent, Inc. |
Symbool | CTLT |
Munteenheid | USD |
Prijs | 59.41 |
Beurswaarde | 10,783,627,920 |
Dividendpercentage | 0% |
52-weken bereik | 32.38 - 61.2 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Alessandro Maselli |
Website | https://www.catalent.com |
An error occurred while fetching data.
Over Catalent, Inc.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)